Search

everythinglearnresearchcommunity

for

Search:↓

Men typically shed about 10 hairs in 60 seconds, and this amount doesn't increase with age.

CTE and FPHL are different hair loss types with unique causes.

The clinic-based hair fall count method is accurate and reliable.

Hair loss from telogen effluvium can cause mental health issues and lower life quality, needing both medical and emotional support.

Minoxidil increases hair weight and count temporarily in men with hair loss.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Low iron levels are not directly linked to chronic hair loss and iron supplements may not help.

Olive leaf compound oleuropein helps grow hair in mice.

Finasteride may not stop severe hair loss after stopping minoxidil.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.

The HPV vaccine may be linked to temporary hair loss in children, but the benefits outweigh the risks.

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

AA-PRP injections effectively increase hair count and thickness for male pattern hair loss.

One supplement improved hair loss and quality faster and more effectively than the other in treating telogen effluvium.

Different genes are active in dogs' hair growth and skin, similar to humans, which helps understand dog skin and hair diseases and can relate to human conditions.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

The belief about hair shedding phases is likely incorrect and needs reevaluation.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Hair care products with placental growth factor can improve hair thickness and density in postpartum hair loss.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

Iron deficiency is linked to hair loss in CTE patients.

People with chronic hair loss may have a higher chance of Vitamin B12 deficiency.

Low ferritin and zinc levels, as well as anemia, are linked to more severe hair loss in Egyptian children with chronic hair shedding.

ALRV5XR effectively promotes hair regrowth in both men and women through different mechanisms.

Higher iron levels in the blood are not linked to increased hair loss in women.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.